Sale!

Can Assist Breast Test Cost

Original price was: 17,420 د.إ.Current price is: 15,680 د.إ.

-10%

The “Can Assist Breast Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to evaluate the risk of breast cancer by analyzing genetic markers. This test, priced at 15,680 AED, utilizes advanced genetic sequencing technologies to assess the individual’s susceptibility to breast cancer. It examines specific DNA segments for mutations and variations that are known to increase the risk of developing the disease. By providing personalized risk assessment, the “Can Assist Breast Test” aids in early detection and enables patients and healthcare providers to make informed decisions about preventive measures and tailored screening schedules. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant advancement in personalized medicine and cancer prevention strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CAN ASSIST BREAST Test

At DNA Labs UAE, we offer the CAN ASSIST BREAST Test for breast cancer diagnosis. This test is specifically applicable for breast cancer patients who are ER positive, PR positive, and Her2 negative. It is an important test in guiding treatment decisions for breast cancer patients.

Test Details

The CAN ASSIST BREAST Test is performed using immunohistochemistry method. It involves analyzing a formalin fixed paraffin embedded tissue block sample. The test can only be conducted if a duly filled Can Assist-Breast Test Requisition Form (Form 41) is submitted.

Test Components and Price

The cost of the CAN ASSIST BREAST Test is 15680.0 AED.

Sample Condition and Submission

The sample should be a formalin fixed paraffin embedded tissue block, which should be shipped at room temperature. The test is applicable only for Breast cancer patients who are ER positive, PR positive, and Her2 negative.

Report Delivery

The sample should be submitted daily by 3.30 pm. The report will be delivered within 15 working days.

Doctor and Test Department

The CAN ASSIST BREAST Test is performed by an Oncologist in the HISTOLOGY department.

Pre Test Information

A duly filled Can Assist-Breast Test Requisition Form (Form 41) is mandatory before conducting the test.

Importance of the CAN ASSIST BREAST Test

The CAN ASSIST BREAST Test is crucial in determining the genotype of the Hepatitis C virus and detecting any mutations in the NS5a gene that may confer resistance to certain antiviral drugs. Genotyping helps in guiding treatment decisions as different genotypes may respond differently to medications. The NS5a gene is a target for direct-acting antiviral drugs used to treat Hepatitis C, and mutations in this gene can lead to drug resistance. Therefore, it is important to identify any such mutations before initiating treatment. The test involves taking a blood sample from the patient, which is then analyzed in a laboratory to determine the genotype and any drug resistance mutations present. The results of this test can help doctors select the most appropriate treatment regimen for their patients with Hepatitis C.

Test Name CAN ASSIST BREAST Test
Components
Price 15680.0 AED
Sample Condition Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Test is applicable only for Breast cancer which is ER positive & PR positive but Her2 negative. Duly filled Can Assist-Breast Test Requisition Form (Form 41)is mandatory.
Report Delivery Sample Daily by 3.30 pm; Report 15 Working days
Method Immunohistochemistry
Test type Breast Cancer
Doctor Oncologist
Test Department: HISTOLOGY
Pre Test Information Duly filled Can Assist-Breast Test Requisition Form (Form 41)is mandatory.
Test Details

The Hepatitis C Viral RNA Genotype 1 NS5a Drug Resistance Test is a diagnostic test used to identify the genotype of the Hepatitis C virus and detect any mutations in the NS5a gene that may confer resistance to certain antiviral drugs.

Genotyping determines the specific strain of the virus and is important in guiding treatment decisions, as different genotypes may respond differently to certain medications.

The NS5a gene is a target for several direct-acting antiviral drugs used to treat Hepatitis C, such as daclatasvir and ledipasvir. Mutations in this gene can lead to drug resistance, making it important to identify any such mutations before initiating treatment.

The test involves taking a blood sample from the patient, which is then analyzed in a laboratory to determine the genotype and any drug resistance mutations present. The results of this test can help doctors select the most appropriate treatment regimen for their patients with Hepatitis C.